Abstract: The invention comprises a composition of matter, method of preparing same, and a method of use. The composition of matter or formulation increases biological activity. The product is both environmentally and physically safe. The formulation in the inventive composition increase the respiration and reproductive rates of most bacteria. Its method of use includes its introduction into a waste water treatment system non-selectively which enhances aerobic biological activity, thereby improving both carbonaceous and nitrogenous removals. The product is especially effective for endogenous situations. The non-selective nature of the product enhances most biological activity, thus allowing for overall performance improvements within a treatment plant. The invention contemplates the method of use of the composition of matter.

Abstract: This invention describes a composition of matter to facilitate intra-dermal delivery of a great variety of active substances, especially including high molecular weight cosmicuticals. Also disclosed is a method of forming the composition of matter and applying topically to patients, especially using a cream or patch. The active substance is initially combined with a biopolymer, which combination is subsequently linked to a base formulation whereby the base formulation aids in the intra-dermal delivery of the active substance without the skin irritation limitations of other formulations and dermal transmitting methods. The use of a combination of natural herbal, vegetable and animal products combined in this invention with biopolymers permits molecules of higher molecule weight to penetrate into the skin in a bioactive form by passive delivery means. The invention includes a product for the improvement of skin health and wrinkle reduction.

Abstract: Disclosed is a composition of matter that features a liquid biocatalyst to stimulate biological activity. The composition is both environmentally and physically safe. The biological simulators in the inventive biocatalyst increase the metabolic and reproductive rates of most bacteria. Its introduction into a waste water treatment system non-selectively enhances aerobic biological activity, thereby improving both carbonaceous and nitrogenous removals. The product is especially effective for endogenous situations. The non-selective nature of the product enhances most biological activity, thus allowing for overall performance improvements within a treatment plant. The inventive composition of matter is made by the blending of Ascophyllum nodosum seaweed extract, Liquid Coconut Oil Soap, Vitamin Mixture, and De-ionized water. Ascophyllum nodosum seaweed is preferably extracted from freshly harvested ascophyllum nodosum seaweed.

Abstract: Provided is an apparatus for gas sampling from a harsh environment which comprises a chemically resistant plastic housing suitable for suspension in a confined spacial environment. The housing has apertures for inlet and outlet tubes by which sampled air is drawn into and then discharged from the housing. Included are two three way valves to control selective fluid communication with the environment, a gas sensor, a filter selectively remove contamination from the housing and prevent saturation of the gas sensor, a pump disposed within the housing to effect selective fluid flow through the gas sensor and filter, and a power source that is preferably batteries. The apparatus electronics are all integrated into an electronics module configured so as to communicate with an external readout in a remote location via several methods.

Abstract: Disclosed is a composition of matter that features a liquid biocatalyst to stimulate biological activity. The composition is both environmentally and physically safe. The biological simulators in the inventive biocatalyst increase the metabolic and reproductive rates of most bacteria. Its introduction into a waste water treatment system non-selectively enhances aerobic biological activity, thereby improving both carbonaceous and nitrogenous removals. The product is especially effective for endogenous situations. The non-selective nature of the product enhances most biological activity, thus allowing for overall performance improvements within a treatment plant. The inventive composition of matter is made by the blending of Ascophyllum nodosum seaweed extract, Liquid Coconut Oil Soap, Vitamin Mixture, and De-ionized water. Ascophyllum nodosum seaweed is preferably extracted from freshly harvested ascophyllum nodosum seaweed.

Abstract: A high molecular weight drug is transdermally administered by applying a polymer skin enhancer and a drug active to the skin of the patient. The drug active has a molecular weight of above 50 daltons and takes at least 15% by weight of the system. The drug may be encapsulated or the drug solution may be partly encapsulated and partly free. The skin enhancer is polyvinylpyrrolidone (PVP) and it is mixed at between 7 and 35% of the drug. A gelling agent may be optionally added at up to 20% by volume. The chemical system is preferably administered via a multidose transdermal drug patch assembly which includes a drug-impervious support impressed to form a series of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The support is adhesively secured to the skin of a patient. Individual devices are provided for resealably enclosing the drug active in each of the reservoirs.

Abstract: A multidose transdermal drug delivery system comprises a laminate composite with a plurality of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The assembly is adhesively secured to the skin of a patient. Individual seals are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing seals are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. Provisions are also made to automatically indicate the activation of the drug and to prevent an accidental release of medicament.

Abstract: A multidose transdermal drug delivery system comprises a laminate composite with a plurality of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The assembly is adhesively secured to the skin of a patient. Individual seals are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing seals are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. Provisions are also made to automatically indicate the activation of the drug and to prevent an accidental release of medicament.

Abstract: A high molecular weight drug is transdermally administered by applying a polymer skin enhancer and a drug active to the skin of the patient. The drug active has a molecular weight of above 500 daltons. The drug may be encapsulated or the drug solution may be partly encapsulated and partly free. The skin enhancer is preferably polyvinylpyrrolidone (PVP) and it is mixed at between 7 and 35% of the drug. A gelling agent may be optionally added at up to 20% by volume. The chemical system is preferably administered via a multidose transdermal drug patch assembly which includes a drug-impervious support impressed to form a series of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The support is adhesively secured to the skin of a patient. Individual devices are provided for resealably enclosing the drug active in each of the reservoirs.

Abstract: A transdermal drug delivery system is disclosed. The system comprises a laminate composite of a patch/skin permeable membrane; a transfer gel layer disposed on said permeable membrane; a permeable membrane disposed on said transfer gel layer; a plurality of sectional drug reservoirs for receiving medicament disposed on the transfer gel layer; and activation means for releasing medicament from said drug reservoirs for contact with skin of a patient. The medicament in contained in the reservoirs at varying amounts and/or concentrations, providing for selectable dosage, for sequential delivery, for sequential activation, for variable unit dose drug delivery in transdermal application.

Abstract: A multi-part system to collect and analyze constituents of body fluid. The use of a multilayered gel matrix to facilitate the collection of analytes fluid and a chemistry detection methodology incorporated into the matrix to aid in the visual or electronic determination of the analyte is described.

Abstract: A drug delivery system for transdermally delivering drugs through a given skin area is provided. The delivery system comprises a collapsible container for containing the drug. The container has a drug release opening. A displaceable member is in engagement with the container for expelling the drug from the container via the release opening. A driver is connected with said displaceable member so as to drive the same towards the collapsible container. Conduits are disposed between the release opening and the skin area for conducting the drug to the skin area. An ultrasonic transducer is disposed in the general conduit area for generating ultrasonic waves aimed at the skin area. An ultrasonic waveform generator drives the transducer and an electric control circuit is connected to the flow control for electrically activating the flow control.

Abstract: A transdermal drug delivery system is disclosed. The system comprises a laminate composite of a patch/skin permeable membrane; a transfer gel layer disposed on said permeable membrane; a permeable membrane disposed on said transfer gel layer; a plurality of sectional drug reservoirs for receiving medicament disposed on the transfer gel layer; and activation means for releasing medicament from said drug reservoirs for contact with skin of a patient. The medicament in contained in the reservoirs at varying amounts and/or concentrations, providing for selectable dosage, for sequential delivery, for sequential activation, for variable unit dose drug delivery in transdermal application.